REQUEST A DEMO
Total
USD $0.00
Search more companies

Immunotech Biopharm Ltd (Hong Kong) (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Immunotech Biopharm Ltd Profile Updated: October 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Immunotech Biopharm Ltd is focused on the development of immunotherapy drugs. The company provides immune cell therapy products for cancer and other major diseases. The company was established in 2018, headquartered in Beijing City, China.

Headquarters
8/F, Block 1, Guosheng Technology Park, No.1 Kangding Street, Beijing Economic-Technological Development Area
Beijing; Beijing; Postal Code: 100176

Contact Details: Purchase the Immunotech Biopharm Ltd (Hong Kong) report to view the information.

Website: http://www.eaal.net

Basic Information
Total Employees:
Purchase the Immunotech Biopharm Ltd (Hong Kong) report to view the information.
Outstanding Shares:
Purchase the Immunotech Biopharm Ltd (Hong Kong) report to view the information.
Registered Capital:
Purchase the Immunotech Biopharm Ltd (Hong Kong) report to view the information.
Financial Auditors:
Purchase the Immunotech Biopharm Ltd (Hong Kong) report to view the information.
Incorporation Date:
April 11, 2018
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
26.22%
Purchase this report to view the information.
10%
Purchase this report to view the information.
6.72%
Purchase this report to view the information.
4.8%
Purchase this report to view the information.
Subsidiaries
Ankang Ruihe Biomedical Technology (Beijing) Co., Ltd. (China)
100%
Beijing Yongtai Ruike Biotechnology Company Ltd (China)
100%
Guangzhou Yongrui Immunobiological Technology Co Ltd (China)
100%
Company Performance
Financial values in the chart are available after Immunotech Biopharm Ltd (Hong Kong) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Total operating revenue
66.06%
Operating profit (EBIT)
-35.94%
EBITDA
-13.24%
Net Profit (Loss) for the Period
21.96%
Total assets
-30.65%
Total equity
-79.8%
Return on Equity (ROE)
-87.57%
Debt to Equity Ratio
41.33%
Quick Ratio
-1.41%
Cash Ratio
-0.6%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?